Your browser doesn't support javascript.
loading
Levels of CSF prostaglandin E2, cognitive decline, and survival in Alzheimer's disease.
Combrinck, M; Williams, J; De Berardinis, M A; Warden, D; Puopolo, M; Smith, A D; Minghetti, L.
Affiliation
  • Combrinck M; The Oxford Project to Investigate Memory and Ageing (OPTIMA), University Department of Pharmacology and Radcliffe Infirmary, Oxford, UK.
J Neurol Neurosurg Psychiatry ; 77(1): 85-8, 2006 Jan.
Article in En | MEDLINE | ID: mdl-15944180
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Dinoprostone / Cognition Disorders / Alzheimer Disease Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male Language: En Journal: J Neurol Neurosurg Psychiatry Year: 2006 Document type: Article Affiliation country: Reino Unido Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Dinoprostone / Cognition Disorders / Alzheimer Disease Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male Language: En Journal: J Neurol Neurosurg Psychiatry Year: 2006 Document type: Article Affiliation country: Reino Unido Country of publication: Reino Unido